Showing results (111-120 of 216) with videos related to
Sort By:
Pageof 22
Rheumatology International|April 30, 1999
Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosisJ Teichmann, U Lange, H Stracke, et al.Acta Diabetologica|December 1, 1996
GAD 65 antibody but not ICA positivity in adult-onset diabetic patients is associated with early progression to clinical insulin dependencyE Hatziagelaki, C Jaeger, E Maeser, et al.Immunitat Und Infektion|July 1, 1987
[Endocrine rhythms in patients with rheumatoid arthritis: possible neurohormonal influence on immunological reactions]G Neeck, K Federlin, V Graef, et al.Zeitschrift Fur Rheumatologie|March 1, 1987
[Circadian rhythm of cortisol and corticotropin (ACTH) in patients with rheumatoid arthritis in relation to inflammatory activity]G Neeck, K Federlin, V Graef, et al.Immunitat Und Infektion|February 1, 1991
[Osteocalcin in rheumatoid arthritis--a marker for accelerated bone turnover in late-onset rheumatoid arthritis?]W Marhoffer, H Stracke, H Schatz, et al.Hormone and Metabolic Research. Supplement Series|January 1, 1990
Treatment of rat pancreatic islets with MHC Ia antibody and complement prior to transplantationB K Flesch, D A Otto, R G Bretzel, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1995
Islet transplantation in immunoseparating membranes for treatment of insulin-dependent diabetes mellitusT Zekorn, A Horcher, U Siebers, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 14, 2008
Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical studyH Stracke, W Gaus, U Achenbach, et al.The Journal of Rheumatology|January 1, 1990
Adrenal secretion of cortisol in patients with rheumatoid arthritisG Neeck, K Federlin, V Graef, et al.The Clinical Investigator|May 1, 1992
Disappearance of a pituitary tumor after 15 months of treatment with CV 205-502, a new dopamine agonistW J Fassbender, H Stracke, G Bachmann, et al.Pageof 22